Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
Other Sizes |
|
Targets |
IC50: EV71; bacterial
|
---|---|
ln Vitro |
Mosloflavone inhibits TNF-α, IL-1β, and iNOS levels in the supernatant of mouse macrophage cell line J774A in a dose-dependent manner. It can also be used as a starting point to find lead structures for the treatment of inflammatory and immunomodulatory diseases[2]. Mosloflavone exhibits promising anti-inflammatory activity via inhibition of TNF-α and IL-1β with IC50 values of 16.4 uM and 6.4 uM, respectively.
|
References |
|
Additional Infomation |
Mosloflavone is a member of flavonoids and an ether.
Mosloflavone has been reported in Desmos dumosus, Mosla soochowensis, and other organisms with data available. |
Molecular Formula |
C17H14O5
|
---|---|
Molecular Weight |
298.2901
|
Exact Mass |
298.084
|
CAS # |
740-33-0
|
PubChem CID |
471722
|
Appearance |
Light yellow to yellow solid powder
|
Density |
1.3±0.1 g/cm3
|
Boiling Point |
508.5±50.0 °C at 760 mmHg
|
Melting Point |
163-164ºC (chloroform , acetone )
|
Flash Point |
190.5±23.6 °C
|
Vapour Pressure |
0.0±1.4 mmHg at 25°C
|
Index of Refraction |
1.622
|
LogP |
2.74
|
Hydrogen Bond Donor Count |
1
|
Hydrogen Bond Acceptor Count |
5
|
Rotatable Bond Count |
3
|
Heavy Atom Count |
22
|
Complexity |
440
|
Defined Atom Stereocenter Count |
0
|
InChi Key |
SIVAITYPYQQYAP-UHFFFAOYSA-N
|
InChi Code |
InChI=1S/C17H14O5/c1-20-14-9-13-15(16(19)17(14)21-2)11(18)8-12(22-13)10-6-4-3-5-7-10/h3-9,19H,1-2H3
|
Chemical Name |
5-hydroxy-6,7-dimethoxy-2-phenylchromen-4-one
|
Synonyms |
5-Hydroxy-6,7-dimethoxylflavone;F4DL1FN60Q;
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~50 mg/mL (~167.62 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: 2.5 mg/mL (8.38 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.3524 mL | 16.7622 mL | 33.5244 mL | |
5 mM | 0.6705 mL | 3.3524 mL | 6.7049 mL | |
10 mM | 0.3352 mL | 1.6762 mL | 3.3524 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.